Answers are grounded in this paper and cite their sources.
mutation of the proofreading domain is characterized by hypermutated phenotype and might derive benefit from immune checkpoint inhibition. In the present work, we aim to review the most recent literature regarding treatment with ICIs in mCRC, focusing on dMMR/MSI-H and special subgroups of CRC patients. Hence, we summarize possible future targets and the most promising predictive biomarkers.
No takes yet. Share an insight, caveat, or question.
Borelli et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: